Norman Balcazar

Dr. Norman Balcazar

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2020 in Pharmaceutical Research
Verified
Journal Article
Closed access
PDF file
DCDiana Colorado
Diana Colorado
MFMaritza Fernandez
Maritza Fernandez
JOJahir Orozco
Jahir Orozco
YLYasmin Lopera
Yasmin Lopera
DMDiana Lorena Muñoz
Diana Lorena Muñoz
NBNorman Balcazar
Norman Balcazar

2 March 2020 in Nutritional Neuroscience
Verified
Journal Article
Closed access
PPP. A. Pérez-Corredor
P. A. Pérez-Corredor
JGJ. A. Gutiérrez-Vargas
J. A. Gutiérrez-Vargas
LCL. Ciro-Ramírez
L. Ciro-Ramírez
NBNorman Balcazar
Norman Balcazar
GCGloria Patricia Cardona-Gomez
Gloria Patricia Cardona-Gomez
Objectives: Cerebral ischemia is caused by a reduction of the blood flow in a specific area in the brain, triggering cellular cascades in the tissue that result in neuronal death. This phenomenon leads to neurological decline in patients with stroke. The extent of the injury after stroke could be related to the condition of obesity. Thus, we aim to analyze the effect of obesity induced by a high fructose diet (HFD) on the brain after cerebral ischemia in rats. Methods: We induced the obesity model in female Wistar rats with 20% fructose in water for 11 weeks. We then performed cerebral ischemia surgery (2-vessel occlusion), carried out the neurological test 6, 24 and 48 h post-ischemia and analyzed the histological markers. Results: The HFD induced an obese phenotype without insulin resistance. The obese rats exhibited worse neurological performance at 6 h post-ischemia and showed neuronal loss and astroglial and microglial immunoreactivity changes in the caudate putamen, motor cortex, amygdala and hippocampus at 48 h post-ischemia. However, the most commonly affected area was the hippocampus, where we found an increase in interleukin 1β in the blood vessels of the dentate gyrus, a remarkable disruption of MAP-2+ dendrites, a loss of brain-derived neurotrophic factor and the presence of PHF-tau. In conclusion, a HFD induces an obese phenotype and worsens the neuronal loss, inflammation and plasticity impairment in the hippocampus after cerebral ischemia.

1 January 2021 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
Sergio AcínSergio Acín
Sergio Acín
DMDiana Lorena Muñoz
Diana Lorena Muñoz
AGAlis Guillen
Alis Guillen
DSDuberney Soscue
Duberney Soscue
ACAdriana Castaño
Adriana Castaño
NBNorman Balcazar
Norman Balcazar

9 April 2015 in Molecules
Verified
Journal Article
Open access
PDF file
SGSergio Granados
Sergio Granados
NBNorman Balcazar
Norman Balcazar
AGAlis Guillén
Alis Guillén
FEFernando Echeverri
Fernando Echeverri
Jatropha gossypifolia L. (Euphorbiaceae) is a plant widely used in the treatment of type 2 diabetes mellitus (T2DM), but there are few scientific reports validating its activity in this area. In this work and through a bioguided assay, a crude extract stimulated glucose uptake in C2C12 myotubes up to 30%, thereby reducing insulin resistance induced by fatty acids compared to the basal control. A chromatographic fraction applied intraperitoneally (IP) in mice reduced glucose by 42% in a mouse model of T2DM, after administration of 10 doses during 20 days. A flavanone was purified from this active fraction and its structure was assigned by 1H- and 13C-NMR (1D and 2D) and MS. This compound retains the previously reported activity, stimulating in vitro the glucose uptake in a concentration-dependent manner. This study indicates that Jatropha gossypifolia L. extracts enhance glucose uptake in cultured myotubes and adipocytes and also improving glucose tolerance in an in vivo model.

1 November 2018 in Phytomedicine
Verified
Journal Article
Closed access
SCSusana Ceballos
Susana Ceballos
AGAlis Guillén
Alis Guillén
DMDiana Lorena Muñoz
Diana Lorena Muñoz
ACAdriana Castaño
Adriana Castaño
LELuis Fernando Echeverri
Luis Fernando Echeverri
NBNorman Balcazar
Norman Balcazar

15 April 2021 in Molecules
Verified
Journal Article
Open access
PDF file
NBNorman Balcazar
Norman Balcazar
LBLaura I. Betancur
Laura I. Betancur
DMDiana L. Muñoz
Diana L. Muñoz
FCFrankly J. Cabrera
Frankly J. Cabrera
ACAdriana Castaño
Adriana Castaño
Sergio AcínSergio Acín
Sergio Acín
Obesity has a strong relationship to insulin resistance and diabetes mellitus, a chronic metabolic disease that alters many physiological functions. Naturally derived drugs have aroused great interest in treating obesity, and triterpenoids are natural compounds with multiple biological activities and antidiabetic mechanisms. Here, we evaluated the bioactivity of ursolic acid lactone (UAL), a lesser-known triterpenoid, obtained from Eucalyptus tereticornis. We used different cell lines to show for the first time that this molecule exhibits anti-inflammatory properties in a macrophage model, increases glucose uptake in insulin-resistant muscle cells, and reduces triglyceride content in hepatocytes and adipocytes. In 3T3-L1 adipocytes, UAL inhibited the expression of genes involved in adipogenesis and lipogenesis, enhanced the expression of genes involved in fat oxidation, and increased AMP-activated protein kinase phosphorylation. The range of biological activities demonstrated in vitro indicates that UAL is a promising molecule for fighting diabetes.